LYMPHOGENIC METASTASIS IN LUMINAL-TYPE A BREASR CANCER

QR Code

LYMPHOGENIC METASTASIS IN LUMINAL-TYPE A BREASR CANCER

The present study has found significant heterogeneity of luminal A breast cancer group, which is manifested by differences in relationship between the frequency of lymphogenic metastasis and morphologic and molecular-biological parameters of the primary tumor. The frequency of regional metastases ha...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. V. Zavjalova, N. S. Telegina, S. V. Vtorushin, V. M. Perelmute, E. M. Slonimskaya, E. V. Denisov, N. V. Cherdyntseva, S. V. Patalyak, N. A. Skryabin, K. Yu. Khristenko
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:	Сибирский онкологический журнал
Subjects:	breast cancer luminal a breast cancer lymphogenic metastasis
Online Access:	https://www.siboncoj.ru/jour/article/view/93
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MORPHOLOGICAL STUDY OF LUMINAL BREAST CANCER
by: M. V. Zavyalova, et al.
Published: (2016-02-01)

ROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL BREAST CANCER
by: Е. М. Slonimskaya, et al.
Published: (2016-02-01)

Role of proteasome system in prognosis of breast cancer progression
by: E. E. Shashova, et al.
Published: (2018-09-01)

ROR1 and BMI-1 proteins as potential predictors of the effectiveness of hormone therapy in luminal breast cancer
by: V. O. Tarakanova, et al.
Published: (2022-06-01)

RELATIONSHIP BETWEEN PARAMETERS OF TUMOR NEOANGIOGENESIS AND LYMPHOGENOUS METASTASIS IN PATIENTS WITH RECTAL CANCER
by: I. V. Stepanov, et al.
Published: (2017-07-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01)

A LINK BETWEEN AUTOPHAGY REGULATORY PROTEINS M-TOR AND BECLIN-1 AND PARAMETERS OF LYMPHOGENIC METASTASIS IN COLORECTAL CANCER
by: S. V. Vtorushin, et al.
Published: (2018-09-01)

ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE
by: N. N. Babyshkina, et al.
Published: (2017-06-01)

Studying GATA3, FOXA1, and ELF5 transcription factors in the evaluation of prognosis in luminal breast cancer patients
by: S. V. Vtorushin, et al.
Published: (2021-01-01)

Immunological and molecular genetic characteristics of luminal B breast cancer: a literature review
by: D. A. Ryabchikov, et al.
Published: (2017-02-01)

ASSOCIATION BETWEEN SPECIFIC FEATURES OF GATA3 TRANSCRIPTION FACTOR EXPRESSION AND LYMPH NODE METASTASIS IN LUMINAL BREAST CANCER
by: S. V. Vtorushin, et al.
Published: (2017-11-01)

Clinicopathological Profile Of Her2 Positive (Non-Luminal) Breast Cancer Subtype At Haji Adam Malik General Hospital From 2020-2021
by: Yosua Natanael, et al.
Published: (2024-01-01)

EWING SARCOMA: FEATURES OF LYMPHOGENOUS METASTASIS AND PROGNOSTIC FACTORS
by: N. V. Vasilyev, et al.
Published: (2019-11-01)

VEGFA GENE POLYMORPHISM (С-2578A, C+936T) IN PATIENTS WITH BREAST CANCER
by: A. V. Shevchenko, et al.
Published: (2014-07-01)

Generalized lymphogenous metastasis involving parenchymal organs in gastric cancer (case report)
by: M. V. Zavyalova, et al.
Published: (2025-03-01)

LOGISTICS OF LYMPHOGENIC BREAST CANCER METASTASIS
by: Sh. Kh. Gantsev, et al.
Published: (2017-01-01)

COMMUNICATION OF HEMATOGENOUS DISSEMINATION FROM LYMPH NODE METASTASIS FOR DIFFERENT MOLECULAR-GENETIC VARIANTS OF BREAST CANCER
by: N. S. Telegina, et al.
Published: (2013-12-01)

Serous endometrial carcinoma with cardiac metastasis (a case report)
by: M. V. Zavyalova, et al.
Published: (2023-08-01)

Treatment of luminal HER2-negative breast cancer: opinion of experts
by: E. V. Artemeva, et al.
Published: (2024-06-01)

Expression of E- and N-cadherins in tumor in luminal, primary operable breast cancer without Her2/neu overexpression in postmenopausal women as a prognostic factor
by: V. V. Tokmakov, et al.
Published: (2020-12-01)

The impact of ROR1, BMI-1 expression and <i>PIK3CA</i> mutation on the prognosis of luminal breast cancer
by: S. V. Vtorushin, et al.
Published: (2025-05-01)

Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor
by: M. K. Ibragimova, et al.
Published: (2020-10-01)

RELATIONSHIP BETWEEN EXPRESSION OF MATRIX METALLOPROTEINASES AND MORPHOLOGICAL HETEROGENEITY, TUMOR DIFFERENTIATION AND LYMPHOGENOUS METASTASIS OF SQUAMOUS CELL LARYNGEAL CARCINOMA
by: О. V. Savenkova, et al.
Published: (2016-02-01)

Metformin as an adjuvant option for systemic treatment of breast cancer
by: D.I. Avierin, et al.
Published: (2023-12-01)

PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER
by: N. A. Kozyavin, et al.
Published: (2018-08-01)

FEATURES OF BILATERAL BREAST CANCER NODAL METASTASIS
by: Ye. A. Fesik, et al.
Published: (2014-12-01)

CHARACTERISTICS OF BILATERAL BREAST CANCER HEMATOGENOUS METASTASIS
by: E. A. Fesik, et al.
Published: (2016-02-01)

Features of gene polymorphism associations linked with sex hormone binding globulin level and breast cancer of various molecular biological subtypes
by: K. N. Pasenov, et al.
Published: (2024-01-01)

HETEROGENENOUS EXPRESSION OF MARKERS ASSOCIATED WITN INVASIVE BREAST CANCER
by: N. V. Krakhmal, et al.
Published: (2016-10-01)

PROGNOSTIC SIGNIFICANCE OF THE EPITHELIAL-MESENCHYMAL TRANSITION MARKERS AND MORPHOLOGICAL CHARACTERISTICS OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS IN THE DEVELOPMENT OF LYMPHOGENOUS METASTASES
by: V. A. Bychkov, et al.
Published: (2020-01-01)

Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal <i>BRCA1</i>-associated breast cancer to triple negative subtype in lung metastasis and PARP inhibition strategy in early-line therapy
by: A. I. Stukan, et al.
Published: (2022-12-01)

CORRELATION BETWEEN CHEMOTHERAPY RESPONSE AND EXPRESSION PROFILES OF TRANSMEMBRANE PROTEINS: P-GLYCOPROTEIN (ABCB1), MRP2 (ABCC2), BCRP (ABCG2) IN PATIENTS WITH INVASIVE BREAST CANCER
by: К. Yu. Khristenko, et al.
Published: (2016-10-01)

Polymorphic variants of the <i>hOGG1, APEX1, XPD, SOD2</i>, and <i>CAT</i> genes involved in DNA repair processes and antioxidant defense and their association with breast cancer risk
by: А. А. Timofeeva, et al.
Published: (2024-07-01)

Subpopulation composition of PD-L1-positive lymphocytes in the primary tumour in luminal breast cancer patients
by: L. A. Tashireva, et al.
Published: (2024-07-01)

Cost-effectiveness of lymphadenectomy in patients with early breast cancer luminal type A
by: S. M. Demidov, et al.
Published: (2015-07-01)

PALBOCICLIB IN COMBINATION WITH HORMONE THERAPY FOR LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER: NEW HIGHLY EFFECTIVE STRATEGY OF DRUG TREATMENT
by: E. V. Artamonova
Published: (2017-09-01)

The influence of functional skewness on prognosis of cancer of mammary gland
by: L. E. Erendeeva, et al.
Published: (2002-03-01)

The diagnostic and therapeutic potential of exosomal proteins in breast cancer
by: A. A. Shefer, et al.
Published: (2023-07-01)

Association of integrin expression in tumor tissue with hematogenic metastasis of breast cancer
by: M. V. Zavyalova, et al.
Published: (2024-01-01)

PREDICTIVE VALUE OF MOLECULAR PARAMETERS IN PATIENTS WITH BASAL-LIKE TRIPL-NEGATIVE BREAST CANCER
by: О. D. Bragina, et al.
Published: (2016-02-01)